FeesSafety
Pluang+

NASDAQ falls 5.3% in October, worst tech selloff since March 2025 amid debt fears and high valuations

Market News
03 Nov 2026, 16:38 WIB
Seeking Alpha
View Source
Bearish
NASDAQ falls 5.3% in October, worst tech selloff since March 2025 amid debt fears and high valuations

In October, the NASDAQ dropped 5.3%, marking its worst monthly performance since March 2025, driven by sharp declines in tech and neocloud stocks like CoreWeave and Nebius, which fell over 35% due to debt concerns and bleak industry forecasts. Despite this tech selloff, the broader market remains highly overvalued with the Shiller P/E ratio near levels seen during the Internet Boom, and about 60% of S&P 500 stocks are in a stealth bear market, down 20% or more from their highs. This suggests underlying market weakness despite high valuations, raising caution for investors going forward.

The story about the stealth bear market provides context for the technology sector's performance on Pluang as of Nov 03, 2026 21:01 WIB. Among 150 priced Technology-sector US stocks, 80 rose while 69 fell today. Notably, VERI dropped 4.70% to USD 0.58 with a nearly balanced sell/buy order activity, contrasting with KLAC and LRCX which rose over 4.5% to USD 160.23 and USD 237.96 respectively, despite heavy sell order activity of 77% and 91%. Typical hold times range from 16 days for VERI to over 60 days for KLAC and LRCX, highlighting varied investor engagement within the sector.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
4 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
4 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
4 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App